Literature DB >> 21463904

Memory cells specific for myelin oligodendrocyte glycoprotein (MOG) govern the transfer of experimental autoimmune encephalomyelitis.

Jessica L Williams1, Aaron P Kithcart, Kristen M Smith, Todd Shawler, Gina M Cox, Caroline C Whitacre.   

Abstract

Multiple sclerosis (MS) is an inflammatory disease of the CNS mediated by CD4(+) T cells directed against myelin antigens. Experimental autoimmune encephalomyelitis (EAE) is induced by immunization with myelin antigens like myelin oligodendrocyte glycoprotein (MOG). We have explored the transfer of EAE using MOG(35-55)-specific TCR transgenic (2D2) T cells. Unsorted 2D2 Th1 cells reliably transferred EAE. Further, we found that CD44(hi)CD62L(lo) effector/memory CD4(+) T cells are likely responsible for the disease transfer due to the up-regulation of CD44. Given the importance of MOG in MS pathogenesis, mechanistic insights into adoptively transferred EAE by MOG-specific Th1 cells could prove valuable in MS research.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21463904      PMCID: PMC3690522          DOI: 10.1016/j.jneuroim.2011.02.008

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  36 in total

1.  A novel transcription factor, T-bet, directs Th1 lineage commitment.

Authors:  S J Szabo; S T Kim; G L Costa; X Zhang; C G Fathman; L H Glimcher
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

2.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

3.  Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.

Authors:  B Bielekova; B Goodwin; N Richert; I Cortese; T Kondo; G Afshar; B Gran; J Eaton; J Antel; J A Frank; H F McFarland; R Martin
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

4.  Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment.

Authors:  Magdalena J Polanczyk; Bryan D Carson; Sandhya Subramanian; Michael Afentoulis; Arthur A Vandenbark; Steven F Ziegler; Halina Offner
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

5.  Bimolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T cell extravasation.

Authors:  Animesh Nandi; Pila Estess; Mark Siegelman
Journal:  Immunity       Date:  2004-04       Impact factor: 31.745

6.  Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes.

Authors:  C B Pettinelli; D E McFarlin
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

7.  Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis.

Authors:  R Egg; M Reindl; F Deisenhammer; C Linington; T Berger
Journal:  Mult Scler       Date:  2001-10       Impact factor: 6.312

8.  Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis.

Authors:  Christopher Lock; Guy Hermans; Rosetta Pedotti; Andrea Brendolan; Eric Schadt; Hideki Garren; Annette Langer-Gould; Samuel Strober; Barbara Cannella; John Allard; Paul Klonowski; Angela Austin; Nagin Lad; Naftali Kaminski; Stephen J Galli; Jorge R Oksenberg; Cedric S Raine; Renu Heller; Lawrence Steinman
Journal:  Nat Med       Date:  2002-05       Impact factor: 53.440

Review 9.  Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis.

Authors:  Scott S Zamvil; Lawrence Steinman
Journal:  Neuron       Date:  2003-06-05       Impact factor: 17.173

10.  Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis.

Authors:  Estelle Bettelli; Maria Pagany; Howard L Weiner; Christopher Linington; Raymond A Sobel; Vijay K Kuchroo
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

View more
  9 in total

1.  Bystander-mediated stimulation of proteolipid protein-specific regulatory T (Treg) cells confers protection against experimental autoimmune encephalomyelitis (EAE) via TGF-β.

Authors:  Sangmu Jun; Javier Ochoa-Repáraz; Dagmara Zlotkowska; Teri Hoyt; David W Pascual
Journal:  J Neuroimmunol       Date:  2012-03-13       Impact factor: 3.478

2.  Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation.

Authors:  Michihito Kono; Kayaho Maeda; Irina Stocton-Gavanescu; Wenliang Pan; Masataka Umeda; Eri Katsuyama; Catalina Burbano; Seo Yeon K Orite; Milena Vukelic; Maria G Tsokos; Nobuya Yoshida; George C Tsokos
Journal:  JCI Insight       Date:  2019-06-20

3.  Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS.

Authors:  Stefan Bittner; Tobias Ruck; Michael K Schuhmann; Alexander M Herrmann; Hamid Moha ou Maati; Nicole Bobak; Kerstin Göbel; Friederike Langhauser; David Stegner; Petra Ehling; Marc Borsotto; Hans-Christian Pape; Bernhard Nieswandt; Christoph Kleinschnitz; Catherine Heurteaux; Hans-Joachim Galla; Thomas Budde; Heinz Wiendl; Sven G Meuth
Journal:  Nat Med       Date:  2013-08-11       Impact factor: 53.440

4.  Immunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitis.

Authors:  Courtney A McDonald; Natalie L Payne; Guizhi Sun; Leon Moussa; Christopher Siatskas; Rebecca Lim; Euan M Wallace; Graham Jenkin; Claude C A Bernard
Journal:  J Neuroinflammation       Date:  2015-06-03       Impact factor: 8.322

5.  Trichloroethylene-induced alterations in DNA methylation were enriched in polycomb protein binding sites in effector/memory CD4+ T cells.

Authors:  Kathleen M Gilbert; Sarah J Blossom; Brad Reisfeld; Stephen W Erickson; Kanan Vyas; Mary Maher; Brannon Broadfoot; Kirk West; Shasha Bai; Craig A Cooney; Sudeepa Bhattacharyya
Journal:  Environ Epigenet       Date:  2017-09-06

6.  A role for cathepsin Z in neuroinflammation provides mechanistic support for an epigenetic risk factor in multiple sclerosis.

Authors:  Euan R O Allan; Rhiannon I Campden; Benjamin W Ewanchuk; Pankaj Tailor; Dale R Balce; Neil T McKenna; Catherine J Greene; Amy L Warren; Thomas Reinheckel; Robin M Yates
Journal:  J Neuroinflammation       Date:  2017-05-10       Impact factor: 8.322

7.  Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells.

Authors:  Gisela M Vaitaitis; Martin G Yussman; Dan M Waid; David H Wagner
Journal:  PLoS One       Date:  2017-02-13       Impact factor: 3.240

8.  In vivo modification of tRNA with an artificial nucleobase leads to full disease remission in an animal model of multiple sclerosis.

Authors:  Sreeja Varghese; Michelle Cotter; Franciane Chevot; Claire Fergus; Colm Cunningham; Kingston H Mills; Stephen J Connon; John M Southern; Vincent P Kelly
Journal:  Nucleic Acids Res       Date:  2017-02-28       Impact factor: 16.971

Review 9.  Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis.

Authors:  Océane Perdaens; Vincent van Pesch
Journal:  Front Neurol       Date:  2022-02-25       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.